Comparison of Peripheral Blood Markers in Predicting the Occurrence of Immune-Related Adverse Events in Patients with Metastatic Genitourinary Cancer Treated with Cabozantinib + Nivolumab +/- Ipilimumab.
JOURNAL OF CLINICAL ONCOLOGY(2023)
关键词
Biomarkers for Immunotherapy,Prognostic Markers,Tumor Microenvironment
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要